LIFS
Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. Life Stem Genetics Inc. has a strategic collaborative agreement with American CryoStem Corporation. The company was founded in 2012 and is based in Beverly Hills, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | 0.00 | $0 | — |
| 2025 Q2 | 0.00 | $0 | — |
| 2025 Q1 | 0.00 | $0 | — |
| 2025 Q4 | 0.00 | $0 | — |
| 2025 Q3 | -0.00 | $0 | — |
| 2024 Q2 | 0.00 | $0 | — |
| 2024 Q1 | -0.00 | $0 | — |
| 2024 Q4 | -0.00 | $0 | — |